Hepatic T cells and liver tolerance
The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
The T-cell biology of the liver is unlike that of any other organ. The local lymphocyte population is enriched in natural killer (NK) and NKT cells, which might have crucial roles in the recruitment of circulating T cells. A large macrophage population and the efficient trafficking of dendritic cells from sinusoidal blood to lymph promote antigen trapping and T-cell priming, but the local presentation of antigen causes T-cell inactivation, tolerance and apoptosis. These local mechanisms might result from the need to maintain immunological silence to harmless antigenic material in food. The overall bias of intrahepatic T-cell responses towards tolerance might account for the survival of liver allografts and for the persistence of some liver pathogens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“LSECs are the port of entry to the liver for circulating immune cells and can function as resident antigen-presenting cells, promoting immunotolerance under physiological conditions [296].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [296]
Citations
Cites
1 retracted
RETRACTED: Autoimmunity as a Consequence of Retrovirus-Mediated Expression of C-FLIP in Lymphocytes
Parijs, L. V., Refaeli, Y., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80150-8 · Cited by 149
RetractedA Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952 · cited 1×
“This would be a unique situation, because resting naive T cells do not have access to most tissues, which are selectively populated with long-lived memory T cell”
BackgroundLethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
The Liver: Biology and Pathobiology.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,590
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“The migration of DCs seems to be controlled by chemokine”
BackgroundImmature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?
Lutz, M. B., & Schuler, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02281-0 · Cited by 1,349 · cited 1×
“cgi?l=7124">TNF ), and such DCs prime CD4 + T cells to deliver an immune respons”
BackgroundAnalysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245 · cited 1×
“cgi?l=3600">IL-15 , which promotes the survival of CD8 + T cell”
Background
Research works printed but not linked: 3
- Bertolino, P., Trescol-Biemont, M. C. & Rabourdin-Combe, C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 28, 221–236 (1998). One explanation for liver tolerance is that antigen presentation by non-professional antigen-presenting cells, such as hepatocytes, causes T-cell apoptosis. This paper describes experiments in favour of this theory. · DOI · Paper page
- Granucci, F., Vizzardelli, C., Virzi, E., Rescigno, M. & Ricciardi-Castagnoli, P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur. J. Immunol. 31, 2539–2546 (2001). · DOI
- Lechner, F. et al. CD8+ T-lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479–2487 (2000). · DOI · Paper page
Cited by
Items 301–400 of 658
Development of Murine Hepatic NK Cells during Ontogeny: Comparison with Spleen NK Cells
Wu, X., Chen, Y., Wei, H., Sun, R., & Tian, Z. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/759765 · Cited by 30
“The liver must eliminate the blood toxic waste products and endotoxins or other bacterial degradation products from the gut, without eliciting an immune response in the normal condition, so the liver acts as a complex immune organ, functioning as a site of effective immune responses or of tolerance appropriately [28,…”
BackgroundImmunological aspect of the liver and metastatic uveal melanoma
Terai, M., Mastrangleo, M. J., & Sato, T. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.39 · Cited by 31
“Based on the published literatures[13,29,30, 41,45-49] and our limited institutional experience, we propose the following twophase growth model for metastatic UM in the liver.”
MethodSerum Amyloid A Proteins and Their Impact on Metastasis and Immune Biology in Cancer
Lee, J., & Beatty, G. L. (2021) · Cancers · doi:10.3390/cancers13133179 · Cited by 30
Grace, P. M., Hutchinson, M. R., Bishop, A., Somogyi, A. A., Mayrhofer, G., & Rolan, P. E. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.11.018 · Cited by 33
“Some, in particular activated T cells, might enter non-lymphoid organs such as the liver (Crispe, 2003) and the CNS (Hickey et al.”
BackgroundThe Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease
Braß, A., & Brenndörfer, E. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034747 · Cited by 33
“This enables the mature DC to migrate to lymphoid tissues in response to CCL21 for efficient antigen presentation [59,69].”
BackgroundGut immune response in the presence of hepatitis C virus infection
Hetta, . F. (2014) · World Journal of Immunology · doi:10.5411/wji.v4.i2.52 · Cited by 28
Amiya, T., Nakamoto, N., Chu, P., Teratani, T., Nakajima, H., Fukuchi, Y., Taniki, N., Yamaguchi, A., Shiba, S., Miyake, R., et al. (2016) · Scientific Reports · doi:10.1038/srep35146 · Cited by 31
Thomas, S., Kolumam, G. A., & Murali‐Krishna, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5802 · Cited by 28
“Lm, in contrast, predominantly infects macrophages, dendritic cells, and a limited repertoire of nonhemopoietic cells, especially hepatocytes, which are generally known to provide a strong tolerization signal to activated T cells (35), although under some conditions the liver may be an excellent priming site for naive…”
BackgroundBonorino, P., Leroy, V., Dufeu‐Duchesne, T., Tongiani-Dashan, S., Stürm, N., Pernollet, M., Vivier, É., Zarski, J., Marche, P. N., & Jouvin‐Marche, E. (2007) · Hepatology · doi:10.1002/hep.21850 · Cited by 35
“CD45RA (%) 72 (47-85) 55 (42-68) 76 (47-84) 68 (55-92) CD45RAhigh (%) 64 (36-71) 46 (23-57) 68 (37-72) 59 (37-83) CD45RO (%) 21 (16-34) 44 (37-53) 28 (16-31) 37 (15-48) CD27 (%) 90 (72-96) 81 (37-92) 92 (69-97) 79 (42-94) CD28 (%) 79 (52-96) 71 (57-79) 86 (58-93) 79 (37-91) CD62L (%) 40 (26-73) 32 (27-41) 61 (41-77) 3…”
InfluentialResearch Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Li, W., Chen, G., Peng, H., Zhang, Q., Nie, D., Guo, T., Zhu, Y., Zhang, Y. M., & Lin, M. (2024) · Biomolecules · doi:10.3390/biom14091161 · Cited by 30
“However, the unique anatomical location of the liver leads to immune tolerance towards antigens from the gut [6], while the presence of immune inhibitory molecules and cells in the tumor microenvironment inhibits the immune function of DCs.”
BackgroundBaseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC
Dercle, L., Fronheiser, M. P., Rizvi, N. A., Hellmann, M. D., Maier, S., Hayes, W., Yang, H., Guo, P., Fojo, T., Schwartz, L. H., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.12.019 · Cited by 28
Immunotherapy for liver tumors: present status and future prospects
Matar, P., Alaniz, L. D., Rozados, V. R., Aquino, J. B., Malvicini, M., Atorrasagasti, C., Gidekel, M., Silva, M., Scharovsky, O. G., & Mazzolini, G. D. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-30 · Cited by 32
Animal models of autoimmune hepatitis
Czaja, A. J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.42 · Cited by 27
Myers, L. M., Messer, R. J., Carmody, A., & Hasenkrug, K. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900350 · Cited by 27
“Thus, the liver is not purely tolerogenic and can adapt responses according to homeostatic signals (39).”
BackgroundLalazar, G., Yaʼacov, A. B., Lador, A., Livovsky, D. M., Pappo, O., Preston, S., Hareati, M., & Ilan, Y. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.009 · Cited by 27
“Treatment with GC, LC, and IGL in ConA-treated animals decreased intrahepatic CD8+ T cell trapping (Crispe, 2003; Crispe et al., 2006).”
BackgroundSuzuki, M., Chiocca, E. A., & Saeki, Y. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300273 · Cited by 27
Hepatic consequences of vascular adhesion protein-1 expression
Weston, C. J., & Adams, D. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0647-0 · Cited by 30
“Although murine models can help understand the role of VAP-1 in leukocyte recruitment, it is important to recognise that differences exist in the leukocyte composition of murine and human livers, which mean that findings need to be confirmed wherever possible in human systems ( Crispe 2003; Mestas and Hughes 2004).”
BackgroundInfluentialHanvesakul, R., Kubal, C. A., Moore, J., Neil, D., Cook, M. A., Ball, S. T., Briggs, D., Moss, P. A. H., & Cockwell, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023631 · Cited by 26
Autoimmune Hepatitis in Brazil: An Overview
Goldberg, A. C., Bittencourt, P. L., de Oliveira, L. C., Ramasawmy, R., Marin, M. L. C., Palácios, S. A., Kalil, J. E., & Porta, G. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01967.x · Cited by 26
Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C
Larrubia, J. R., Martínez, S. B., Miquel, J., Calvino, M., Sanz‐de‐Villalobos, E., & Parra-Cid, T. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5129 · Cited by 33
Pugh, S. A., Harrison, R. J., Primrose, J. M., & Khakoo, S. I. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-180 · Cited by 27
“However, as a site of early encounter of antigens the liver must be tolerogenic to dietary antigens and commensal organisms at the same time as being able to mount an effective immune response to pathogens or tumour cells [18,19].”
BackgroundIntrahepatic CD4+ Cell Depletion in Hepatitis C Virus/HIV???Coinfected Patients
Canchis, P. W., Yee, H. T., Fiel, M. I., Dieterich, D. T., Liu, R.-C., Chiriboga, L. A., Jacobson, I. M., Edlin, B. R., & Talal, A. H. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000131937.52106.92 · Cited by 26
“Alternatively, activated CD8 cells may migrate to the liver lobule where they undergo apoptosis.(6) The decrease in intrahepatic CD4 cells, as a consequence of HIV-associated cell death,(20) may partially account for increased HCV RNA levels that have been observed in coinfected patients.”
BackgroundActivation of NOD1 and NOD2 in the development of liver injury and cancer
Omaru, N., Watanabe, T., Kamata, K., Minaga, K., & Kudo, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004439 · Cited by 28
“The liver is exposed to various bacterial components and metabolites derived from the intestinal microbiota via the portal vein (1).”
BackgroundImmune cell regulation of liver regeneration and repair
Markose, D., Kirkland, P., Ramachandran, P., & Henderson, N. C. (2018) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2018.03.003 · Cited by 30
Wu, B., Chen, Q.-H., Pan, D., Chang, B., & Sang, L.-X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107790 · Cited by 26
Kelly, M., Zhuo, J., Bharadwaj, A. S., & Chao, H. (2009) · Molecular Therapy · doi:10.1038/mt.2009.25 · Cited by 26
Tolerance: Is It Achievable in Pediatric Solid Organ Transplantation?
Seyfert‐Margolis, V., & Feng, S. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.01.015 · Cited by 27
Yoshida, O., Dou, L., Kimura, S., Yokota, S., Isse, K., Robson, S. C., Geller, D. A., & Thomson, A. W. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.01.003 · Cited by 28
“The liver is regarded as a lymphoid organ with a unique constituency of immune cells [1–3] and exhibits inherent tolerogenic properties [3–5] These include oral and portal venous tolerance and allograft acceptance in rodents or pigs, without dependence on any immunosuppressive therapy [6, 7].”
BackgroundNew Animal Models for Autoimmune Hepatitis
Christen, U., Hintermann, E., & Jaeckel, E. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1233536 · Cited by 25
Suzuki, M., Chiocca, E. A., & Saeki, Y. (2008) · Molecular Therapy · doi:10.1038/mt.2008.175 · Cited by 25
LIVER TRANSPLANTATION-INDUCED ANTIHISTONE H1 AUTOANTIBODIES SUPPRESS MIXED LYMPHOCYTE REACTION
Nakano, T., Kawamoto, S., Lai, C.-Y., Sasaki, T., Aki, T., Shigeta, S., Goto, T., Sato, S., Goto, S., Chen, C., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000123079.10650.71 · Cited by 25
“, dendritic cells, Kupffer cells, liver sinusoidal endothelial cells) would be critical for maintenance of the tolerogenic state (11, 12).”
BackgroundLiver Metastasis in Cancer: Molecular Mechanisms and Management
Xu, W., Xu, J., Liu, J., Wang, N., Zhou, L., & Guo, J. (2025) · MedComm · doi:10.1002/mco2.70119 · Cited by 30
“Liver metastases affect immunotherapy efficacy by altering the body’s antitumor response [344, 345].”
Holz, L. E., Benseler, V., Vo, M., McGuffog, C., van Rooijen, N., McCaughan, G. W., Bowen, D. G., & Bertolino, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.015 · Cited by 25
Guo, J., Bao, X., Liu, F., Guo, J., Wu, Y., Xiong, F., & Lu, J. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s416933 · Cited by 24
“TACE times 2~12 2~6 Systemic treatment, N (%) 2 (7) 1 (4) Radiofrequency ablation, N (%) 9 (33) 12 (44)”
Yadav, N., Kanjirakkuzhiyil, S., Ramakrishnan, M., Das, T. K., & Mukhopadhyay, A. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0569 · Cited by 24
“Further, the tolerogenic properties of the liver may have an important role in the expression of FVIII by hepatocytes in HA mice; these properties are lacking in the peritoneal cavity [37–39].”
New Insights into Hbv Replication: New Opportunities for Improved Therapies
Nassal, M. (2008) · Future Virology · doi:10.2217/17460794.4.1.55 · Cited by 29
Ren, J., Meng, S., Yan, B., Yu, J., & LIU, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4980 · Cited by 24
“…of pro‑inflammatory cytokines is associated with recruitment and activation of immune cell infiltration, which results in aberrant expression of inflammatory genes, ultimately resulting in hepatitis or other diseases (such as lung injury, lung cancer, gastritis and neurogenic inflammation) (9).”
Adetutu, A., Olorunnisola, O. S., Owoade, A. O., & Adegbola, P. I. (2016) · Malaria Research and Treatment · doi:10.1155/2016/9248024 · Cited by 24
Fonseca, L., Seixas, E., Butcher, G. A., & Langhorne, J. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-77 · Cited by 24
Margalit, M., Ilan, Y., Ohana, M., Safadi, R., Alper, R., Sherman, Y., Doviner, V., Rabbani, E., Engelhardt, D., & Nagler, A. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704719 · Cited by 24
Guardascione, M., & Toffoli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176302 · Cited by 24
Immune responses to malaria pre‐erythrocytic stages: Implications for vaccine development
Abuga, K. M., Jones‐Warner, W., & Hafalla, J. C. R. (2020) · Parasite Immunology · doi:10.1111/pim.12795 · Cited by 30
Oku, H., Li, C., Shimatani, M., Iwasaki, H., Toda, T., Okabe, T., & Watanabe, H. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0896-2 · Cited by 25
Deng, Z., Zhuang, X., Ju, S., Xiang, X., Mu, J., Wang, Q., Jiang, H., Zhang, L., Kronenberg, M., Yan, J., et al. (2012) · Hepatology · doi:10.1002/hep.26086 · Cited by 25
Murata, Y., Kawashima, K., Sheikh, K., Tanaka, Y., & Isogawa, M. (2018) · Journal of Virology · doi:10.1128/jvi.00920-18 · Cited by 23
“The liver is widely regarded as a tolerogenic organ (21).”
BackgroundMikami, Y., Mizuno, S., Nakamoto, N., Hayashi, A., Sujino, T., Sato, T., Kamada, N., Matsuoka, K., Hisamatsu, T., Ebinuma, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084619 · Cited by 24
Vascular Adhesion Protein‐1 as a Potential Therapeutic Target in Liver Disease
Lalor, P. F., TUNCER, C., Weston, C. J., Martín-Santos, A., SMITH, D. J., & Adams, D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.051 · Cited by 23
Zigmond, E., Shalev, Z., Pappo, O., Alper, R., Zolotarov, L., & Ilan, Y. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.07.003 · Cited by 23
Chen, X., Ren, A., Zheng, L., Zheng, E., & Jiang, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651086 · Cited by 25
Mesenchymal stem cells-based therapy in liver diseases
Han, H., Jin, W., & Li, X. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00088-x · Cited by 25
“However, in the context of liver diseases, profound and complex changes in the hepatic immune microenvironment occur, which have a dramatic impact on the occurrence and development of the liver diseases [62, 63].”
BackgroundLópez-Álvarez, M. R., Moya‐Quiles, M. R., Minguela, A., Gil, J., Miras, M., Campillo, J. A., Díaz-Alderete, M. A., García-Alonso, A. M., Bueno, F. S., Vicario, J. L., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181af7d84 · Cited by 25
“Effectively, NK cells may influence the liver graft damage or the tolerance (42), because within the liver they are activated cells (43), their proportion is much higher than in peripheral blood (44), and fully functional NK cells have been observed in rejected liver grafts (45).”
BackgroundImmunomodulatory, liver depot gene therapy for Pompe disease
Bond, J. E., Kishnani, P. S., & Koeberl, D. D. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.011 · Cited by 24
Martínez, M. B., Rodríguez, M. A., García‐Rivera, G., Sánchez, T., Hernández‐Pando, R., Aguilar, D., & Orozco, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.051 · Cited by 23
Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation
John, B., Klein, I., & Crispe, I. N. (2006) · Hepatology · doi:10.1002/hep.21446 · Cited by 22
Self-citationResident Immune Cells of the Liver in the Tumor Microenvironment
Lu, Y., Ma, S., Ding, W., Sun, P., Zhou, Q., Duan, Y., & Sartorius, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931995 · Cited by 25
Sankar, K. N., Pearson, A. N., Worlikar, T., Perricone, M. D., Holcomb, E. A., Mendiratta‐Lala, M., Xu, Z., Bhowmick, N. A., & Green, M. D. (2023) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-11 · Cited by 22
“Low levels of co-stimulatory CD80/86 and elevated levels of PD-L1 on hepatocytes during antigen presentation to T cells lead to dysfunctional T cell activation (106,110,111).”
Role of stress‐induced NKG2D ligands in liver diseases
Kahraman, A., Fingas, C. D., Syn, W., Gerken, G., & Canbay, A. E. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02608.x · Cited by 21
“Unique to the liver is the abundance of natural killer (NK) and NKT cells, where they constitute approximately 25–40% of isolated liver leukocytes (1, 2).”
Lipid-Coated Calcium Phosphate Nanoparticles for Nonviral Gene Therapy
Haynes, M. T., & Huang, L. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00007-9 · Cited by 24
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine
Fujii, H., Seki, S., Kobayashi, S., Kitada, T., Kawakita, N., Adachi, K., Tsutsui, H., Nakanishi, K., Fujiwara, H., Ikarashi, Y., et al. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1265-8 · Cited by 21
“In pathological conditions, they are activated, and play roles in the defense against microbes and tumor cells [ 6 , 12, 38].”
BackgroundInduction of immune tolerance: a role for Natural killer T lymphocytes?
Margalit, M., & Ilan, Y. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01147.x · Cited by 21
“They are most abundant in the liver, spleen, and bone marrow (2).”
BackgroundIn Vivo Luminescent Imaging of Cyclosporin A???Mediated Cancer Progression in Rats
Ohsawa, I., Murakami, T., Üemoto, S., & Kobayashi, E. (2006) · Transplantation · doi:10.1097/01.tp.0000209448.50238.de · Cited by 22
“Although the resident immune cell population of the liver is unlike that of any other organ (25), intrahepatic lymphocytes have not been well-characterized after CsA administration.”
BackgroundKawashita, Y., Deb, N. J., Garg, M. K., Kabarriti, R., Fan, Z., Alfieri, A. A., Roy‐Chowdhury, J., & Guha, C. (2014) · Radiation Research · doi:10.1667/rr13617.1 · Cited by 20
“nature of the HCC microenvironment, which hampers the generation of immune-mediated systemic protection (29, 30).”
BackgroundHuang, S., Wu, J., Gao, X., Zou, S., Chen, L., Yang, X., Sun, C., Du, Y., Zhu, B., Li, J., et al. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.002 · Cited by 21
“…in gut-derived food and bacterial degradation products and by liver resident cells with unique functions, such as liver sinusoidal endothelial cells (LSECs), hepatocytes, Kupffer cells (KCs) and DCs, which are involved in antigen-specific tolerance induction (Breous et al., 2009; Crispe, 2003).”
BackgroundLiver immunity and tumour surveillance
Canning, C., O’Brien, M., Hegarty, J. E., & O’Farrelly, C. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.07.002 · Cited by 24
CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver
Kenna, T., O’Brien, M., Hogan, A. E., Exley, M. A., Porcelli, S. A., Hegarty, J. E., O’Farrelly, C., & Doherty, D. G. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0215-x · Cited by 23
“The liver is notable for its ability to induce immunological tolerance to dietary antigens entering from the hepatic portal vein [ 13 ] despite having multiple lymphocyte populations that display potent Th1 activities ex vivo [16, 43].”
Tr1 regulatory T cells induced by ConA pretreatment prevent mice from ConA-induced hepatitis
Ye, F., Yan, S., Xu, L., Jiang, Z., Liu, N., Xiong, S., Wang, Y., & Chu, Y. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.01.005 · Cited by 19
Identification of tolerant recipients following liver transplantation
Fueyo, A. S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.011 · Cited by 18
Immunosuppression in liver tumors: opening the portal to effective immunotherapy
Guha, P., Reha, J. L., & Katz, S. C. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.54 · Cited by 20
Hepatic antigen-presenting cells and regulation of liver transplant outcome
Thomson, A. W., Geller, D. A., Gandhi, C. R., Murase, N., Demetris, A. J., & Beer–Stolz, D. (2011) · Immunologic Research · doi:10.1007/s12026-011-8223-0 · Cited by 19
“Liver immunology is the consequence of a complex interplay between multiple liver-resident APC and diverse populations of lymphocytes (NK, NKT, and conventional T cells), overall considered to mediate immune regulatory activity [1, 2, 10].”
BackgroundHIV Infection and TLR Signalling in the Liver
Crane, M., Visvanathan, K., & Lewin, S. R. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/473925 · Cited by 19
“While the liver is constantly exposed to bacterial microflora resident in the gastrointestinal (GI) tract via the portal circulation the inflammatory response is generally averted in the healthy liver by modulation of the innate immune response, referred to as “immune tolerance” (as reviewed by [19–21]).”
BackgroundRole of interleukin-18 in intrahepatic inflammatory cell recruitment in acute liver injury
Kimura, K., Sekiguchi, S., Hayashi, S., Hayashi, Y. K., Hishima, T., Nagaki, M., & Kohara, M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710412 · Cited by 20
“These cells are derived from blood monocytes and found mainly in the hepatic sinusoid [3].”
BackgroundDikopoulos, N., Wegenka, U. M., Kröger, A., Häuser, H., Schirmbeck, R., & Reimann, J. (2004) · Hepatology · doi:10.1002/hep.20173 · Cited by 18
“of these experimental models; and (3) “bystander” hepatitis develops during the intrahepatic accumulation of large numbers of recently activated CD8 T cells.”
BackgroundIs the liver an important site for the development of immune tolerance to tumours?
Jewell, A. P. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.10.002 · Cited by 18
Chang, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i25.3472 · Cited by 18
Korten, S., Anderson, R. J., Hannan, C. M., Sheu, E. G., Sinden, R. E., Gadola, S. D., Taniguchi, M., & Hill, A. V. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.849-858.2005 · Cited by 20
“This supports the concept of the liver as a Th2-driving environment (10, 27) and might be relevant for vaccine design and studies with multiple poxvirus booster immunizations at short intervals, which have occasionally revealed reduced vaccine efficacy (3).”
BackgroundInfluentialThe effects of anti-histone H1 antibody on immune cells responsible for rejection reaction
Hsu, L., Goto, S., Nakano, T., Lai, C.-Y., Kao, Y. H., Lin, Y., Kawamoto, S., Ono, K., Lord, R. J., Goto, T., et al. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.010 · Cited by 18
“Some papers have pointed out the importance of clonal deletion or apoptosis of donor-reactive T-cells, induction of regulatory T-cells, and poor maturation of liver antigen-presenting cells (APCs) (such as dendritic cells (DCs), Kupffer cells, and liver sinusoidal endothelial cells) in the induction and maintenance of…”
BackgroundBéland, K., Lapierre, P., Djilali-Saiah, I., & Álvarez, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048192 · Cited by 20
Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection
He, F., Chen, Z., Xu, S., Cai, M., Wu, M., Hong-zhou, L., & Chen, X. (2009) · Surgery · doi:10.1016/j.surg.2009.01.016 · Cited by 17
Insights Into Human Intrahepatic NK Cell Function From Single Cell RNA Sequencing Datasets
Jameson, G., & Robinson, M. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649311 · Cited by 23
Fas Ligand Is Responsible for CXCR3 Chemokine Induction in CD4+ T Cell-Dependent Liver Damage
Cruise, M. W., Lukens, J. R., Nguyen, A. P., Lassen, M. G., Waggoner, S. N., & Hahn, Y. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6235 · Cited by 19
“Besides the ability of the liver to process and detoxify the blood from toxins, the liver can trap and subsequently deactivate or delete activated T cells from the body (2, 3).”
BackgroundZhang, H., Stolz, D. B., Chalasani, G., & Thomson, A. W. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12126 · Cited by 19
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_144 · Cited by 19
“Subsequently, CXCL9 induces recruitment of virus-specific T cells (Crispe 2003).”
Hsu, L.-W., Chen, C. L., Nakano, T., Lai, C.-Y., Chiang, K., Lin, Y., Kao, Y. H., Chen, S., Goto, T., Sung, W., et al. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03652.x · Cited by 17
Tokita, D., Ohdan, H., Onoe, T., Hara, H., Tanaka, Y., & Asahara, T. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00045.x · Cited by 17
“It has been postulated that the liver might be a site for induction of tolerance to exogenous major histocompatibility complex (MHC) class II-restricted antigens (food) entering the organ in large amounts via portal circulation from the gut [1,2].”
BackgroundExpression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants
Kwekkeboom, J., Kuijpers, M. A. R., Bruyneel, B., Mancham, S., de Baar-Heesakkers, E., Ijzermans, J., Bouma, G. J., Zondervan, P. E., Tilanus, H. W., & Metselaar, H. J. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02129.x · Cited by 18
Kawashita, Y., Deb, N. J., Garg, M. K., Kabarriti, R., Alfieri, A. A., Takahashi, M., Roy‐Chowdhury, J., & Guha, C. (2014) · Radiation Research · doi:10.1667/rr13594.1 · Cited by 17
Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis
Watanabe, T., Katsukura, H., Chiba, T., Kita, T., & Wakatsuki, Y. (2007) · Gut · doi:10.1136/gut.2007.121251 · Cited by 17
Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?
Christen, U., & Hintermann, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898615 · Cited by 19
Teixeira, R., Marcos, L. A., & Friedman, S. L. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00085.x · Cited by 19
Kuhs, K. A. L., Toporovski, R., Ginsberg, A. A., Shedlock, D. J., & Weiner, D. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052165 · Cited by 16
Characterization of the cellular immune response in hepatitis C virus infection
Zhang, X., Dou, J., & Germann, M. W. (2009) · Medicinal Research Reviews · doi:10.1002/med.20157 · Cited by 19
“The liver is the primary replication site of HCV; analyses of LILs reveal distinct features from those obtained with PBMCs.202 The immunological environment in the liver is potentially tolerogenic to LILs.203 Liver sinusoidal endothelial cells, Kupffer cells, stellate cells, and liver DCs may mediate this tolerogenic…”
BackgroundKhairani, S., Fauziah, N., Wiraswati, H. L., Panigoro, R., Setyowati, E. Y., & Berbudi, A. (2022) · Journal of Tropical Medicine · doi:10.1155/2022/5721449 · Cited by 16
“+e absence of macrophages may be due to a decreased proinflammatory immune response, as shown in previous studies [45, 47, 48].”
ResultInfantile hepatic dysfunction improved by elimination of cows’ milk formulas
Saito, M. K., Obi, M., & Kimura, M. (2005) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2005.00256.x · Cited by 16
“Therefore, the liver has been considered to play an important role in the induction of T-cell tolerance (7).”
BackgroundAlexandropoulos, K., Bonito, A. J., Weinstein, E. J., & Herbin, O. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011980 · Cited by 16
“develop with a lower frequency compared to other autoimmune conditions, such as type 1 diabetes (T1D) and multiple sclerosis (MS) [18–22].”
BackgroundCebula, M., Ochel, A., Hillebrand, U., Pils, M. C., Schirmbeck, R., Häuser, H., & Wirth, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068720 · Cited by 19
Chen, D., Xie, H., Cha, H., Qu, J., Wang, M., Lu, L., Yu, S., Wu, C. Y., Tang, X., & Huang, J. (2016) · Immunology · doi:10.1111/imm.12623 · Cited by 16
Parenchymal Expression of CD86/B7.2 Contributes to Hepatitis C Virus-Related Liver Injury
Sun, J., Tumurbaatar, B., Jia, J., Diao, H., Bodola, F., Lemon, S. M., Tang, W. W., Bowen, D. G., McCaughan, G. W., Bertolino, P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10730-10739.2005 · Cited by 16
“Activation and retention of CD8 T cells in the liver can inflict damage to neighboring hepatocytes through IFN- and TNF- (7, 13).”
BackgroundGarside, P., & Brewer, J. M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00587.x · Cited by 18
Serotonin receptor 5-HT 2A as a potential target for HCC immunotherapy
Tay, R. E., Ho, C. M., Ang, N. D. Z., Tay, H. C., Lopez, D. Z., Na, Q. R., Tan, Y. W., Koh, S. M., Tan, K. P., Lee, W., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011088 · Cited by 18
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future
Wei, H., Dong, C., & Li, X. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00462 · Cited by 21
“29 Liver inflammation due to infection by HBV or HCV leads to the recruitment of cytokines and other immune molecules that can promote cancer proliferation.”
Background
Metadata
- Authors
- Crispe, I. N.
- Affiliations
- University of Rochester Medicine (US)
- Corresponding author
- Crispe, Ian Nicholas
- ORCID
- Crispe, Ian Nicholas
- Venue
- Nature Reviews Immunology
- Published
- 2003-01
- Volume
- 3
- Issue
- 1
- Pages
- 51-62
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2074238518
- Cited by
- 661
- References
- 173
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 18 · 2023: 16 · 2022: 19 · 2021: 25 · 2020: 22 · 2019: 19 · 2018: 19 · 2017: 14 · 2016: 21 · 2015: 21 · 2014: 26 · 2013: 34 · 2012: 32
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver tolerance, natural killer cells, NKT cells, dendritic cells, antigen trapping, T cell priming, T cell inactivation, apoptosis, immune tolerance, food antigens, hepatic macrophages
- MeSH terms
- Animals, Hepatitis B, Hepatitis C, Humans, Immune Tolerance, Liver, Liver Circulation, Malaria, CD4-Positive T-Lymphocytes, Liver Transplantation, Apoptosis, Antigen Presentation, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.